Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics
@article{Highlander2010CurrentPC, title={Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics}, author={Peter Highlander and G. P. Shaw}, journal={Therapeutic Advances in Cardiovascular Disease}, year={2010}, volume={4}, pages={43 - 54} }
With the growing worldwide obesity epidemic, obesity, type 2 diabetes mellitus and hypertension leading to premature cardiovascular events, are increasingly prevalent. Diabetes mellitus is a significant public health concern and more aggressive management of the condition and its complications, particularly cardiovascular disease, is warranted. Endothelial cell dysfunction is now known to be present at the earliest stages of metabolic syndrome, and insulin resistance and may precede the… Expand
Topics from this paper
24 Citations
Endothelial dysfunction - a major mediator of diabetic vascular disease.
- Biology, Medicine
- Biochimica et biophysica acta
- 2013
- 496
- PDF
Role of Heme Oxygenases in Cardiovascular Syndromes and Co-morbidities
- Medicine
- Current pharmaceutical design
- 2018
- 4
- PDF
Assessment of Microvascular Function in Children and Adolescents with Diabetes and Obesity
- Medicine
- International journal of endocrinology and metabolism
- 2020
- PDF
References
SHOWING 1-10 OF 128 REFERENCES
Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus
- Medicine
- Vascular health and risk management
- 2005
- 15
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease.
- Medicine
- The American journal of cardiology
- 2003
- 217
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
- Medicine
- The New England journal of medicine
- 2003
- 4,039
The statins in prevention of coronary heart diseases in type 2 diabetics.
- Medicine
- Bosnian journal of basic medical sciences
- 2009
- 16
- PDF
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
- Medicine
- JAMA
- 2004
- 697
- PDF
Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin.
- Medicine
- Cardiovascular research
- 2001
- 86
- PDF